FLUPAROXAN IN MALE ERECTILE DISORDER - A CASE-REPORT

During a protocol study for the efficacy of fluparoxan (a noradrenegic alpha(2)-antagonist) in depression, a positive effect on male erectil e impotence has been observed in one case, with no important secondary effects. This result confirms the involvement of alpha(2)-antagonsts in the handling of male impotence. The action on the erectile disorder appeared slightly before the antidepressive effect (2-3 weeks) and la sted for 6 weeks after the discontinuation of treatment, suggesting th at the effects on impotence were not a mere reflection of the antidepr essive action.